Braidwell’s 89bio ETNB Stock Holding History

Braidwell’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-164,227	Closed	-$1.32M	–	83
2024 Q2	$1.32M	Buy	+164,227	New	+$1.47M	0.04%	75
2023 Q4	–	Sell	-1,590,387	Closed	-$24.6M	–	80
2023 Q3	$24.6M	Buy	+1,590,387	New	+$26.7M	0.78%	46

Other funds holding ETNB

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Braidwell's ETNB Position: Q3 2024 in Review

Braidwell sold out of 89bio (ETNB) in Q3 2024, closing a stake of 164,227 shares — an estimated $1.32M sold.

Braidwell first reported a position in ETNB in Q3 2023 and held it in 2 quarters. The position peaked at $24.6M in Q3 2023. 144 funds tracked by Wall St. Rank hold ETNB as of Q3 2024.

Braidwell reported no remaining 89bio position as of Q3 2024 after selling out during the quarter.
Braidwell sold 164,227 89bio shares in Q3 2024, an estimated $1.32M.
Braidwell first reported a position in 89bio in Q3 2023 and held it in 2 quarters.
Braidwell's 89bio position peaked at $24.6M in Q3 2023.
144 funds tracked by Wall St. Rank held 89bio as of Q3 2024.

Based on Braidwell's 13F filing for Q3 2024, filed 14 Nov 2024.